SITC Congratulates 2019 Election Winners

The Society for Immunotherapy of Cancer (SITC) is pleased to share the results of the 2019 SITC Election. The three candidates who received the most votes during the Eleciton, which took place July 10-24, 2019, are:

Newly Elected SITC At-Large Directors

Alessandra Cesano, MD, PhD ESSA Pharma Inc.	Tanja de Gruijl, PhD VU University Medical Center	Stefani Spranger, PhD Koch Institute for Integrative Cancer Research at MIT
Bio & Platform statement	Bio & Platform statement	Bio & Platform statement

Drs. Cesano, de Gruijl and Spranger will commence their three-year terms on the SITC Board of Directors in January 2020.

Thank you to all of the candidates for their dedication and interest in serving our growing society. The society is grateful to the SITC regular and emeritus members who voted in this year’s election.

Also, SITC thanks the following leaders who are serving their final year on the SITC Board:

• At-Large Director Charles G. Drake, MD, PhD (Columbia University Medical Center)
• At-Large Director Leisha A. Emens, MD, PhD (UPMC Hillman Cancer Center)
• At-Large Director Kristen Hege, MD (Celgene Corporation)

SITC regular and emeritus members are eligible to vote annually in the SITC Election. To help choose our future SITC leaders, join SITC, renew your membership, or check your current membership status. 

STUDENT MEMBERS: If you are a student member and have completed your training, you might be eligible to update your membership category and participate in future SITC Elections. Please contact SITC staff at info@sitcancer.org.